Filippo Crea
doi : 10.1093/eurheartj/ehad034
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Pages 431–434
Judith Ozkan
doi : 10.1093/eurheartj/ehac548
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Pages 435–436
Charalambos Antoniades, Parijat Patel, Alexios S Antonopoulos
doi : 10.1093/eurheartj/ehac751
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Pages 437–439
Judith Ozkan
doi : 10.1093/eurheartj/ehac715
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Pages 440–442
Giovanna Liuzzo, Carlo Patrono
doi : 10.1093/eurheartj/ehac721
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Pages 443–444
Susanna Price, Juan Carlos Kaski, Rasha Al-Lamee, William E Boden, Kurt Huber, Jason N Katz, Konstantin Krychtiuk
doi : 10.1093/eurheartj/ehac811
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Pages 445–447
Francesco Cosentino, Nikolaus Marx, Subodh Verma
doi : 10.1093/eurheartj/ehac780
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Pages 448–451
Grace O Dibben, James Faulkner, Neil Oldridge, Karen Rees, David R Thompson, Ann-Dorthe Zwisler, Rod S Taylor
doi : 10.1093/eurheartj/ehac747
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Pages 452–469
Coronary heart disease is the most common reason for referral to exercise-based cardiac rehabilitation (CR) globally. However, the generalizability of previous meta-analyses of randomized controlled trials (RCTs) is questioned. Therefore, a contemporary updated meta-analysis was undertaken.
Sherry L Grace
doi : 10.1093/eurheartj/ehac690
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Pages 470–472
Joo Myung Lee, Hyun Kuk Kim, Keun Ho Park, Eun Ho Choo, Chan Joon Kim, Seung Hun Lee, Min Chul Kim, Young Joon Hong, Sung Gyun Ahn, Joon-Hyung Doh, Sang Yeub Lee, Sang Don Park, Hyun-Jong Lee, Min Gyu Kang, Jin-Sin Koh, Yun-Kyeong Cho, Chang-Wook Nam, Bon-Kwon Koo, Bong-Ki Lee, Kyeong Ho Yun, David Hong, Hyun Sung Joh, Ki Hong Choi, Taek Kyu Park, Jeong Hoon Yang, Young Bin Song, Seung-Hyuk Choi, Hyeon-Cheol Gwon, Joo-Yong Hahn, The FRAME-AMI Investigators
doi : 10.1093/eurheartj/ehac763
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Pages 473–484
In patients with acute myocardial infarction (MI) and multivessel coronary artery disease, percutaneous coronary intervention (PCI) of non-infarct-related artery reduces death or MI.
Shamir R Mehta, Brian P McGrath
doi : 10.1093/eurheartj/ehac786
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Pages 485–487
Daniel Mølager Christensen, Anne-Marie Schjerning, Lærke Smedegaard, Mette Gitz Charlot, Pauline B Ravn, Anne Christine Ruwald, Emil Fosbøl, Lars Køber, Christian Torp-Pedersen, Morten Schou, Thomas Gerds, Gunnar Gislason, Thomas S G Sehested
doi : 10.1093/eurheartj/ehac667
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Pages 488–498
Outcomes after myocardial infarction (MI) improved during recent decades alongside better risk factor management and implementation of guideline-recommended treatments. However, it is unknown whether this applies to stable patients who are event-free 1 year after MI.
Nicolas Danchin
doi : 10.1093/eurheartj/ehac714
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Pages 499–501
Manan Pareek, Kristian H Kragholm, Anna Meta Dyrvig Kristensen, Muthiah Vaduganathan, Jannik L Pallisgaard, Christina Byrne, Tor Biering-Sørensen, Christina Ji-Young Lee, Anders Nissen Bonde, Martin Bødtker Mortensen, Michael Maeng, Emil L Fosbøl, Lars Køber, Niels Thue Olsen, Gunnar H Gislason, Deepak L Bhatt, Christian Torp-Pedersen
doi : 10.1093/eurheartj/ehac629
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Pages 502–512
David A Morrow
doi : 10.1093/eurheartj/ehac749
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Pages 513–515
Javeria Jamal, Hanan Idris, Amir Faour, Wesley Yang, Alison McLean, Sonya Burgess, Ibrahim Shugman, Kathryn Wales, Aiden O’Loughlin, Dominic Leung, Christian Julian Mussap, Craig Phillip Juergens, Sidney Lo, John Kerswell French
doi : 10.1093/eurheartj/ehac661
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Pages 516–528
Pharmaco-invasive percutaneous coronary intervention (PI-PCI) is recommended for patients with ST-elevation myocardial infarction (STEMI)who are unable to undergo timely primary PCI (pPCI).
J J Coughlan, Borja Ibanez
doi : 10.1093/eurheartj/ehac723
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Pages 529–531
Wen Wu, Dai-Min Zhang
doi : 10.1093/eurheartj/ehac756
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Page 532
Lauri Holmström, Samuli Juntunen, Juhani Junttila
doi : 10.1093/eurheartj/ehac765
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Page 533
Hiroyuki Yamamoto, Masayoshi Fujii, Tomofumi Takaya
doi : 10.1093/eurheartj/ehac440
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Page 534
Antonio Iaconelli, Giuseppe Rovere, Domenico D'Amario, Mattia Galli, Tommaso Sanna
doi : 10.1093/eurheartj/ehac536
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Page 535
doi : 10.1093/eurheartj/ehac800
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Page 469
doi : 10.1093/eurheartj/ehac817
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Page 472
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟